NCT00321061View on ClinicalTrials.gov

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 25, 2006

Primary Completion Date

December 2, 2009

Study Completion Date

December 2, 2009

Conditions
HIV Infections
Interventions
DRUG

VRC-HIVDNA016-00, VRC-HIVADV014-00

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00321061 - Phase I Study of Vaccination Schedule of Experimental HIV Vaccines | Biotech Hunter | Biotech Hunter